Evidence map›Paper›PMID 38833965›Full record

ArticleESMO open2024

Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition.

D Marinelli, A Sabatini, E Bengala, F Ciurluini, V Picone, D Santini, F Pietrantonio, D Rossini, C Cremolini

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

D MarinelliDepartment of Experimental Medicine, Sapienza Università di Roma, Rome.
A SabatiniDepartment of Radiological, Oncological and Pathological Sciences, Sapienza Università di Roma, Rome.
E BengalaDepartment of Radiological, Oncological and Pathological Sciences, Sapienza Università di Roma, Rome.
F CiurluiniDepartment of Radiological, Oncological and Pathological Sciences, Sapienza Università di Roma, Rome.
V PiconeDivision of Medical Oncology, Policlinico Umberto I, Rome.
D SantiniDivision of Medical Oncology, Policlinico Umberto I, Rome.
F PietrantonioDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
D RossiniDepartment of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence. Electronic address: danielerossini87@gmail.com.
C CremoliniUnit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsDNA Mismatch RepairImmune Checkpoint InhibitorsMicrosatellite InstabilityHumansNeoplasm MetastasisImmune Checkpoint Inhibitors

Identifiers

PMID38833965
PMCPMC11179058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.